
    
      Hypothesis:

      We request to do a retrospective chart review of patients receiving this therapy to determine
      safety and efficacy of continuous ambulatory home inotropic therapy in children.

      Methods:

      Data will be obtained from CHOA and Coram Home Healthcare, Inc over a two year period,
      January 1, 2004 through December 31, 2005. Data will be collected on approximately 35
      children aged 0-18 years receiving therapy. The length of therapy, type of therapy,
      therapy-related complications, number of readmissions, deaths at home and catheter-related
      infections data will be collected.

      Inclusion Criteria:

      Receiving inotropic support at home Choa patients with Coram Healthcare only
    
  